2Stephen H, Curt F, Elizabeth BC, et al. Noncardiovascular disease out- comes during 6. 8 years of hormone therapy heart and estrogen/pro- gestin replacement study follow-up( HERS 11 ) [ J]. JAMA ,2002,288 (1) :58 -66.
3Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: princip'al and results from the women's health initiative randomized controlled trial[ J], JAMA ,2002,288 (3) :321 - 333.
4Vankrunkelsven P, kellen E, Lousbergh D, et al. Reduction in hor- mone replacement therapy use and declining breast cancer incidence the belgian province of limburg[ J]. Breast Cancer Res Treat,2009, 118(2) :425 -432.
5International Menopause Society. Guidelines for the hormone treatment of women in the menopausal transition and beyond [ J 1. Climacteric, 2004,7(1) :8 -11.
3Stanford JL, Hartge P,Brenton LA, et al. Factors influencing the age at natural menopause [J]. J Chronic Dis, 1987, 40(11):995- 1002.
4Luoto R, Kaprio J, Uutela A. Age at natural menopause and sociodermographic staus in Finland[J].Am J Epidemiol, 1994,139(1):64 -67.
5Gold EB, Bromberger J, Crawford S, et al. Factors associat ed with age at natural menopause in a multiethnic sample of midlife women[J]. Am J Epidermiol, 2001, 153 (9): 865 874.
6Kaczmarek M. The timing of natual menopause in Poland and associated factors[J]. Maturitas, 2007, 57(2),139-153.
7Dhillon HK, Mahmood NM, Singh H. Documentation of self care actions taken for somatic complaints by postmenopausal Malay women living in Kelantan Malaysia [J].Maturitas, 2007,58(3) :241 -248.
8Karasam Z, Seker SE. Factors associated with menopausal symptoms and their relationship with the quality of life among Turkish women[J]. Maturitas, 2007,58(1):75-82.
9Jokinen K, Rautava P, Makinen J, et al. Experience of climacteric symptoms among 42-46 and 52-56-year-old women [J]. Maturitas, 2003, 46(3):199-205.
10Shea JL, Chinese women's symptoms:relation to menopause, age and related attitudes[J].Climacteric, 2006, 9 (1):30-39.
